Peter Thomas Lansbury, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 39 | 2023 | 2775 | 2.690 |
Why?
|
Amyloid | 26 | 2022 | 795 | 2.570 |
Why?
|
Nerve Tissue Proteins | 30 | 2006 | 4462 | 1.990 |
Why?
|
alpha-Synuclein | 34 | 2019 | 723 | 1.970 |
Why?
|
Synucleins | 26 | 2005 | 110 | 1.260 |
Why?
|
Ubiquitin Thiolesterase | 10 | 2009 | 449 | 1.200 |
Why?
|
Amyloid beta-Peptides | 23 | 2022 | 3587 | 1.060 |
Why?
|
Protein Folding | 11 | 2005 | 843 | 0.950 |
Why?
|
Prions | 13 | 2003 | 180 | 0.880 |
Why?
|
Neurodegenerative Diseases | 9 | 2017 | 1061 | 0.840 |
Why?
|
Glucosylceramidase | 6 | 2023 | 124 | 0.820 |
Why?
|
Ligases | 4 | 2002 | 333 | 0.750 |
Why?
|
Alzheimer Disease | 31 | 2022 | 8037 | 0.650 |
Why?
|
Cell Membrane | 6 | 2011 | 3748 | 0.630 |
Why?
|
Superoxide Dismutase | 6 | 2010 | 597 | 0.630 |
Why?
|
Scrapie | 8 | 1997 | 22 | 0.560 |
Why?
|
Microscopy, Atomic Force | 11 | 2007 | 250 | 0.510 |
Why?
|
Circular Dichroism | 12 | 2008 | 354 | 0.510 |
Why?
|
PrPSc Proteins | 8 | 2003 | 32 | 0.500 |
Why?
|
Nerve Degeneration | 4 | 2003 | 748 | 0.490 |
Why?
|
Peptide Fragments | 14 | 2003 | 5097 | 0.490 |
Why?
|
Plaque, Amyloid | 5 | 2022 | 729 | 0.470 |
Why?
|
Yeasts | 2 | 2009 | 285 | 0.450 |
Why?
|
Point Mutation | 5 | 2007 | 1623 | 0.450 |
Why?
|
Amyotrophic Lateral Sclerosis | 6 | 2010 | 1414 | 0.450 |
Why?
|
Neurons | 10 | 2019 | 9338 | 0.400 |
Why?
|
Acid Ceramidase | 2 | 2020 | 19 | 0.380 |
Why?
|
Protein Structure, Secondary | 8 | 2009 | 1246 | 0.370 |
Why?
|
Protein Structure, Quaternary | 4 | 2007 | 436 | 0.370 |
Why?
|
Thiolester Hydrolases | 4 | 2002 | 86 | 0.350 |
Why?
|
Dopamine | 4 | 2008 | 1591 | 0.350 |
Why?
|
Amino Acid Sequence | 22 | 2009 | 13815 | 0.350 |
Why?
|
Prenylation | 1 | 2009 | 37 | 0.340 |
Why?
|
Protein Conformation | 19 | 2008 | 4011 | 0.330 |
Why?
|
Neurofibrillary Tangles | 3 | 2003 | 439 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2002 | 1861 | 0.310 |
Why?
|
Amyloidosis | 5 | 2022 | 795 | 0.310 |
Why?
|
Decision Making | 1 | 2022 | 3887 | 0.310 |
Why?
|
Fungal Proteins | 3 | 2009 | 912 | 0.310 |
Why?
|
Lewy Bodies | 4 | 2002 | 137 | 0.300 |
Why?
|
Mutation | 17 | 2023 | 29786 | 0.300 |
Why?
|
Intracellular Membranes | 3 | 2009 | 390 | 0.290 |
Why?
|
Molecular Sequence Data | 21 | 2006 | 18111 | 0.290 |
Why?
|
Glucosylceramides | 2 | 2023 | 28 | 0.280 |
Why?
|
Protein Precursors | 3 | 2002 | 1154 | 0.280 |
Why?
|
Amino Acid Substitution | 8 | 2009 | 1791 | 0.270 |
Why?
|
Repetitive Sequences, Amino Acid | 2 | 2003 | 95 | 0.260 |
Why?
|
Saccharomyces cerevisiae | 3 | 2011 | 2752 | 0.260 |
Why?
|
Molecular Weight | 8 | 2003 | 2255 | 0.260 |
Why?
|
Mutagenesis | 2 | 2006 | 1266 | 0.250 |
Why?
|
Congo Red | 4 | 2000 | 46 | 0.240 |
Why?
|
Gene Library | 2 | 2005 | 1074 | 0.240 |
Why?
|
Isatin | 1 | 2003 | 5 | 0.240 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 258 | 0.240 |
Why?
|
Cell Aggregation | 1 | 2004 | 244 | 0.240 |
Why?
|
Dimerization | 6 | 2006 | 893 | 0.230 |
Why?
|
Protein Denaturation | 6 | 2006 | 237 | 0.230 |
Why?
|
Endopeptidases | 6 | 2000 | 772 | 0.230 |
Why?
|
Cell Membrane Permeability | 2 | 2002 | 590 | 0.230 |
Why?
|
Protein Binding | 10 | 2009 | 9386 | 0.220 |
Why?
|
Recombinant Proteins | 11 | 2017 | 6622 | 0.220 |
Why?
|
Ultracentrifugation | 5 | 2003 | 182 | 0.220 |
Why?
|
Gaucher Disease | 2 | 2020 | 112 | 0.220 |
Why?
|
Farnesyltranstransferase | 1 | 2022 | 76 | 0.220 |
Why?
|
Chromatography, Gel | 5 | 2008 | 668 | 0.210 |
Why?
|
Structure-Activity Relationship | 9 | 2020 | 3129 | 0.210 |
Why?
|
Ubiquitin | 2 | 2007 | 852 | 0.210 |
Why?
|
Mutation, Missense | 3 | 2002 | 2564 | 0.210 |
Why?
|
Porins | 1 | 2002 | 81 | 0.210 |
Why?
|
Disulfides | 1 | 2004 | 457 | 0.210 |
Why?
|
Enzyme Inhibitors | 4 | 2020 | 3798 | 0.210 |
Why?
|
Myofibrils | 1 | 2002 | 146 | 0.210 |
Why?
|
Oximes | 1 | 2003 | 311 | 0.200 |
Why?
|
Sphingolipids | 1 | 2022 | 159 | 0.200 |
Why?
|
Phospholipids | 2 | 2003 | 784 | 0.190 |
Why?
|
Oxazolone | 1 | 2020 | 60 | 0.190 |
Why?
|
Humans | 86 | 2023 | 744343 | 0.190 |
Why?
|
Allelic Imbalance | 1 | 2021 | 77 | 0.190 |
Why?
|
Cytoplasm | 2 | 2002 | 1539 | 0.180 |
Why?
|
Disease Models, Animal | 6 | 2022 | 18029 | 0.180 |
Why?
|
Models, Molecular | 12 | 2018 | 5456 | 0.180 |
Why?
|
Permeability | 4 | 2003 | 738 | 0.180 |
Why?
|
Kinetics | 8 | 2020 | 6473 | 0.180 |
Why?
|
COS Cells | 3 | 2009 | 1161 | 0.180 |
Why?
|
Protein Processing, Post-Translational | 3 | 2008 | 1990 | 0.180 |
Why?
|
Rhenium | 1 | 1999 | 13 | 0.180 |
Why?
|
Lysosomes | 3 | 2019 | 893 | 0.180 |
Why?
|
Solubility | 8 | 2020 | 1085 | 0.180 |
Why?
|
R-SNARE Proteins | 1 | 2019 | 74 | 0.180 |
Why?
|
Animals | 41 | 2022 | 168757 | 0.170 |
Why?
|
Benzoxazoles | 1 | 2020 | 77 | 0.170 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1836 | 0.170 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 5 | 2000 | 164 | 0.170 |
Why?
|
Memory Disorders | 1 | 2006 | 1184 | 0.170 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 1999 | 1888 | 0.170 |
Why?
|
Synapses | 2 | 2006 | 1728 | 0.160 |
Why?
|
Inclusion Bodies | 1 | 2000 | 279 | 0.160 |
Why?
|
Biopolymers | 4 | 2001 | 189 | 0.160 |
Why?
|
Models, Biological | 9 | 2008 | 9583 | 0.160 |
Why?
|
Allosteric Site | 1 | 2018 | 103 | 0.160 |
Why?
|
Guanidines | 3 | 1997 | 193 | 0.160 |
Why?
|
Prion Diseases | 3 | 1999 | 88 | 0.150 |
Why?
|
Nortriptyline | 1 | 2017 | 81 | 0.150 |
Why?
|
Microscopy, Electron | 5 | 2007 | 2645 | 0.150 |
Why?
|
Computational Biology | 2 | 2010 | 3521 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2007 | 3846 | 0.150 |
Why?
|
Brain | 12 | 2020 | 26385 | 0.150 |
Why?
|
Peptides | 4 | 2003 | 4409 | 0.150 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2010 | 1723 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4803 | 0.140 |
Why?
|
Thermodynamics | 5 | 2006 | 596 | 0.140 |
Why?
|
Genes, Fungal | 1 | 1997 | 455 | 0.140 |
Why?
|
Organometallic Compounds | 1 | 1999 | 665 | 0.130 |
Why?
|
Drug Design | 1 | 2020 | 1076 | 0.130 |
Why?
|
Threonine | 3 | 2000 | 279 | 0.130 |
Why?
|
Half-Life | 3 | 2020 | 661 | 0.120 |
Why?
|
Endopeptidase K | 5 | 2002 | 23 | 0.120 |
Why?
|
Nerve Fibers | 1 | 1997 | 687 | 0.120 |
Why?
|
PrPC Proteins | 3 | 1999 | 37 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2006 | 2839 | 0.110 |
Why?
|
Alanine | 3 | 2000 | 572 | 0.110 |
Why?
|
Periplasmic Proteins | 1 | 1992 | 25 | 0.110 |
Why?
|
Protein Multimerization | 1 | 2018 | 970 | 0.110 |
Why?
|
Mice | 17 | 2022 | 81183 | 0.110 |
Why?
|
Nucleic Acids | 1 | 1995 | 182 | 0.110 |
Why?
|
Binding Sites | 5 | 2020 | 6114 | 0.100 |
Why?
|
Escherichia coli | 5 | 2017 | 4217 | 0.100 |
Why?
|
Antithrombin III | 1 | 1992 | 128 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2023 | 12026 | 0.100 |
Why?
|
Molecular Chaperones | 2 | 2008 | 742 | 0.100 |
Why?
|
Inhibitory Concentration 50 | 2 | 2020 | 459 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2009 | 1338 | 0.100 |
Why?
|
Lewy Body Disease | 2 | 2006 | 229 | 0.100 |
Why?
|
Aging | 3 | 2006 | 8664 | 0.100 |
Why?
|
Macromolecular Substances | 3 | 2003 | 1454 | 0.100 |
Why?
|
Software | 1 | 2005 | 4443 | 0.100 |
Why?
|
Cloning, Molecular | 3 | 2003 | 4320 | 0.090 |
Why?
|
Synaptic Vesicles | 2 | 2002 | 191 | 0.090 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 941 | 0.090 |
Why?
|
Cell Line, Tumor | 6 | 2020 | 16689 | 0.090 |
Why?
|
Adsorption | 2 | 2001 | 201 | 0.090 |
Why?
|
X-Ray Diffraction | 3 | 2000 | 420 | 0.090 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1992 | 404 | 0.090 |
Why?
|
Micelles | 2 | 2008 | 203 | 0.090 |
Why?
|
Molecular Structure | 4 | 2020 | 1899 | 0.090 |
Why?
|
Apolipoproteins E | 1 | 1995 | 1438 | 0.080 |
Why?
|
Benzothiazoles | 2 | 2000 | 248 | 0.080 |
Why?
|
Spectrophotometry, Infrared | 3 | 1993 | 114 | 0.080 |
Why?
|
Peptide Termination Factors | 2 | 1999 | 55 | 0.080 |
Why?
|
Spectrometry, Fluorescence | 2 | 2001 | 689 | 0.080 |
Why?
|
Age of Onset | 3 | 2000 | 3271 | 0.080 |
Why?
|
Solutions | 2 | 2002 | 426 | 0.080 |
Why?
|
Autophagy | 2 | 2008 | 1300 | 0.080 |
Why?
|
Mutant Proteins | 1 | 2010 | 500 | 0.080 |
Why?
|
Phosphoproteins | 3 | 2002 | 2440 | 0.080 |
Why?
|
Chemistry, Physical | 2 | 2000 | 156 | 0.080 |
Why?
|
Brain Chemistry | 3 | 2002 | 981 | 0.080 |
Why?
|
Lipoproteins | 1 | 1992 | 878 | 0.080 |
Why?
|
Chemical Phenomena | 2 | 2000 | 518 | 0.080 |
Why?
|
Cysteine Endopeptidases | 2 | 2007 | 563 | 0.070 |
Why?
|
Models, Neurological | 2 | 2007 | 1774 | 0.070 |
Why?
|
Transformation, Genetic | 1 | 2006 | 192 | 0.070 |
Why?
|
Methionine | 1 | 2009 | 590 | 0.070 |
Why?
|
Cricetinae | 7 | 1998 | 2472 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.070 |
Why?
|
Electroporation | 1 | 2006 | 251 | 0.060 |
Why?
|
Mesocricetus | 4 | 1997 | 252 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 3772 | 0.060 |
Why?
|
Heparin | 1 | 1992 | 1637 | 0.060 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1144 | 0.060 |
Why?
|
Prealbumin | 2 | 2003 | 210 | 0.060 |
Why?
|
Small Molecule Libraries | 1 | 2010 | 720 | 0.060 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 507 | 0.060 |
Why?
|
Neurofibrils | 1 | 2004 | 76 | 0.060 |
Why?
|
Cysteine | 1 | 2009 | 874 | 0.060 |
Why?
|
Serine | 1 | 2008 | 826 | 0.060 |
Why?
|
Cell-Free System | 4 | 1999 | 344 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2022 | 9734 | 0.060 |
Why?
|
Enzyme Stability | 1 | 2004 | 210 | 0.060 |
Why?
|
Multiprotein Complexes | 2 | 2007 | 1119 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6171 | 0.060 |
Why?
|
gamma-Synuclein | 1 | 2003 | 10 | 0.060 |
Why?
|
Lactosylceramides | 1 | 2023 | 15 | 0.060 |
Why?
|
Propanols | 1 | 2003 | 10 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2011 | 1226 | 0.060 |
Why?
|
beta-Synuclein | 1 | 2003 | 14 | 0.060 |
Why?
|
Hydrogen | 1 | 2003 | 164 | 0.060 |
Why?
|
Guanidine | 3 | 1997 | 33 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 1999 | 5708 | 0.050 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2002 | 41 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2008 | 3760 | 0.050 |
Why?
|
Crystallization | 2 | 1995 | 524 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2010 | 1375 | 0.050 |
Why?
|
Thiazoles | 2 | 2000 | 1483 | 0.050 |
Why?
|
Administration, Oral | 2 | 2020 | 3913 | 0.050 |
Why?
|
Huntington Disease | 2 | 2000 | 1124 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2005 | 572 | 0.050 |
Why?
|
Rats | 6 | 2008 | 24260 | 0.050 |
Why?
|
Quinones | 1 | 2001 | 76 | 0.050 |
Why?
|
Genetic Variation | 4 | 2007 | 6544 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 152 | 0.050 |
Why?
|
Phosphatidylglycerols | 1 | 2001 | 34 | 0.050 |
Why?
|
Phosphatidic Acids | 1 | 2001 | 49 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 2088 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 503 | 0.050 |
Why?
|
Levodopa | 1 | 2001 | 219 | 0.050 |
Why?
|
Cell Death | 1 | 2006 | 1706 | 0.050 |
Why?
|
Microsomes | 1 | 2020 | 257 | 0.050 |
Why?
|
Catecholamines | 1 | 2001 | 387 | 0.050 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2022 | 311 | 0.050 |
Why?
|
Cytotoxins | 1 | 2001 | 153 | 0.050 |
Why?
|
Psychosine | 1 | 2020 | 8 | 0.050 |
Why?
|
Amyloid Neuropathies | 1 | 2000 | 15 | 0.050 |
Why?
|
Coloring Agents | 2 | 2000 | 566 | 0.050 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2020 | 32 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13695 | 0.050 |
Why?
|
Microscopy, Polarization | 1 | 2000 | 88 | 0.050 |
Why?
|
Postmortem Changes | 1 | 2000 | 126 | 0.040 |
Why?
|
Transfection | 2 | 2011 | 5892 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 2001 | 573 | 0.040 |
Why?
|
Phosphatidylcholines | 1 | 2001 | 411 | 0.040 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 1999 | 33 | 0.040 |
Why?
|
Organotechnetium Compounds | 1 | 1999 | 137 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2022 | 1121 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 1992 | 3848 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2003 | 13102 | 0.040 |
Why?
|
Hydrolysis | 1 | 2000 | 682 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1726 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2002 | 11725 | 0.040 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2022 | 584 | 0.040 |
Why?
|
Glutathione Peroxidase | 1 | 1999 | 255 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2011 | 0.040 |
Why?
|
Glycerol | 1 | 1999 | 278 | 0.040 |
Why?
|
Particle Size | 1 | 2002 | 1642 | 0.040 |
Why?
|
Proline | 1 | 2000 | 458 | 0.040 |
Why?
|
Caveolins | 1 | 1998 | 104 | 0.040 |
Why?
|
Protein Transport | 2 | 2019 | 1988 | 0.040 |
Why?
|
Encephalopathy, Bovine Spongiform | 1 | 1997 | 6 | 0.040 |
Why?
|
Time Factors | 5 | 2002 | 40075 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2003 | 1730 | 0.040 |
Why?
|
Gene Dosage | 1 | 2002 | 1252 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2000 | 2557 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2203 | 0.040 |
Why?
|
Molecular Conformation | 2 | 2010 | 563 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10943 | 0.040 |
Why?
|
Protein Unfolding | 1 | 2017 | 54 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 1998 | 402 | 0.040 |
Why?
|
Fluorescence | 1 | 2000 | 751 | 0.040 |
Why?
|
Slow Virus Diseases | 1 | 1996 | 4 | 0.040 |
Why?
|
Sodium Chloride | 1 | 1999 | 625 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 1999 | 655 | 0.040 |
Why?
|
Substantia Nigra | 1 | 1998 | 353 | 0.040 |
Why?
|
Light | 1 | 2003 | 1374 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1654 | 0.040 |
Why?
|
Zoonoses | 1 | 1997 | 185 | 0.030 |
Why?
|
Sulfur Radioisotopes | 1 | 1995 | 116 | 0.030 |
Why?
|
Rabbits | 1 | 2002 | 4894 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2001 | 2187 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 587 | 0.030 |
Why?
|
Ultrafiltration | 1 | 1995 | 57 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5179 | 0.030 |
Why?
|
Lipids | 1 | 2007 | 3305 | 0.030 |
Why?
|
Antigens, CD | 2 | 2023 | 4026 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4568 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2170 | 0.030 |
Why?
|
Hydrostatic Pressure | 2 | 2007 | 106 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2017 | 434 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1999 | 1100 | 0.030 |
Why?
|
Apolipoprotein E3 | 1 | 1995 | 97 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2437 | 0.030 |
Why?
|
Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2010 | 1801 | 0.030 |
Why?
|
Axons | 1 | 2022 | 1684 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.030 |
Why?
|
Genome | 1 | 2002 | 1808 | 0.030 |
Why?
|
Antioxidants | 1 | 2001 | 1663 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2009 | 7880 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1801 | 0.030 |
Why?
|
Temperature | 1 | 1999 | 2206 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
Models, Chemical | 1 | 1995 | 626 | 0.030 |
Why?
|
Rats, Wistar | 2 | 2008 | 1901 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1549 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4328 | 0.030 |
Why?
|
Fourier Analysis | 1 | 1992 | 447 | 0.030 |
Why?
|
Models, Genetic | 1 | 2002 | 3494 | 0.030 |
Why?
|
Apolipoprotein E4 | 1 | 1995 | 668 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2019 | 19229 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1992 | 1157 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2001 | 3086 | 0.020 |
Why?
|
Buffers | 1 | 2010 | 147 | 0.020 |
Why?
|
Absorption | 1 | 2010 | 248 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2002 | 17446 | 0.020 |
Why?
|
Drosophila | 1 | 2017 | 1491 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8301 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2645 | 0.020 |
Why?
|
Mitochondria | 1 | 2002 | 3520 | 0.020 |
Why?
|
Uracil | 1 | 2010 | 165 | 0.020 |
Why?
|
Genome, Human | 1 | 2002 | 4420 | 0.020 |
Why?
|
Water | 2 | 2007 | 1395 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4204 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1997 | 2969 | 0.020 |
Why?
|
Tretinoin | 1 | 2011 | 517 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 2050 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4161 | 0.020 |
Why?
|
Species Specificity | 3 | 1997 | 2478 | 0.020 |
Why?
|
Polymers | 1 | 1994 | 1621 | 0.020 |
Why?
|
Phosphorylation | 2 | 2008 | 8436 | 0.020 |
Why?
|
Drug Stability | 1 | 2007 | 291 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2004 | 21746 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11366 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 1996 | 1622 | 0.020 |
Why?
|
Dementia | 1 | 2000 | 2518 | 0.020 |
Why?
|
Virus Replication | 1 | 1993 | 2534 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2000 | 14557 | 0.020 |
Why?
|
Catalysis | 1 | 2006 | 761 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 6103 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 13881 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2004 | 79 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 1999 | 5853 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1866 | 0.020 |
Why?
|
Liposomes | 1 | 2008 | 759 | 0.020 |
Why?
|
PC12 Cells | 1 | 2004 | 330 | 0.020 |
Why?
|
Deuterium Exchange Measurement | 1 | 2003 | 30 | 0.010 |
Why?
|
Male | 6 | 2020 | 350118 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2967 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3282 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 276 | 0.010 |
Why?
|
Phenotype | 1 | 1999 | 16365 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 936 | 0.010 |
Why?
|
Swine | 1 | 1992 | 5917 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5882 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4186 | 0.010 |
Why?
|
Isoelectric Point | 1 | 2000 | 80 | 0.010 |
Why?
|
Sodium Hydroxide | 1 | 2000 | 44 | 0.010 |
Why?
|
Freeze Drying | 1 | 2000 | 98 | 0.010 |
Why?
|
Filtration | 1 | 2000 | 234 | 0.010 |
Why?
|
Solvents | 1 | 2000 | 302 | 0.010 |
Why?
|
Methods | 1 | 1999 | 1129 | 0.010 |
Why?
|
Detergents | 1 | 1998 | 230 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1997 | 6314 | 0.010 |
Why?
|
Glycolipids | 1 | 1998 | 204 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1998 | 547 | 0.010 |
Why?
|
PrP 27-30 Protein | 1 | 1996 | 1 | 0.010 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 1997 | 89 | 0.010 |
Why?
|
United States | 1 | 2005 | 69872 | 0.010 |
Why?
|
Golgi Apparatus | 1 | 1998 | 410 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2000 | 1572 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 1341 | 0.010 |
Why?
|
Caveolin 1 | 1 | 1998 | 263 | 0.010 |
Why?
|
Cetylpyridinium | 1 | 1995 | 8 | 0.010 |
Why?
|
CHO Cells | 1 | 1998 | 1406 | 0.010 |
Why?
|
Tunicamycin | 1 | 1995 | 112 | 0.010 |
Why?
|
Models, Structural | 1 | 1995 | 361 | 0.010 |
Why?
|
Neuroglia | 1 | 2000 | 927 | 0.010 |
Why?
|
Culture Techniques | 1 | 1995 | 554 | 0.010 |
Why?
|
Sheep | 1 | 1997 | 1437 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11483 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1995 | 1827 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 1999 | 1678 | 0.010 |
Why?
|
Glycosylation | 1 | 1995 | 1126 | 0.010 |
Why?
|
Cattle | 1 | 1997 | 3922 | 0.010 |
Why?
|
Female | 2 | 2020 | 380194 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1997 | 1782 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1995 | 1072 | 0.010 |
Why?
|
Cholesterol | 1 | 1998 | 2917 | 0.010 |
Why?
|
Drug Resistance | 1 | 1995 | 1609 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 213383 | 0.000 |
Why?
|